M
agnesium sulf
ate is the d
rug of choice fo
r the p
revention
and cont
rol of seizu
res in the m
an
agement of seve
re p
reecl
ampsi
a/ecl
ampsi
a. Despite its use in vi
rtu
ally 100% of ecl
ampsi
a c
ases in B
razil, m
ate
rn
al mo
rt
ality due to this diso
rde
r still
rem
ains elev
ated. It is
assumed th
at the
re is
a misuse of m
agnesium sulf
ate, le
ading to
a del
ay in the m
an
agement of seve
re c
ases of p
reecl
ampsi
a/ecl
ampsi
a.
absSec_2">Objective
To describe the obstetrician’s perception on the major reasons for underutilizing magnesium sulfate in severe preeclampsia/eclampsia.
absSec_3">Method
A qualitative clinical study, based on phenomenological reference was carried out by semi-structured interviews and open-ended discussions with obstetricians of the public healthcare system in primary care units (PCU) and referral maternity hospitals (RMH), in Brazil.
absSec_4">Results
Fear instilled by awareness of the risk of drug toxicity was the major cause for not prescribing the medication in PCU. Fear was justified by insufficient technical, structural and organizational resources of healthcare facilities and by a shortage of physicians properly trained for correct drug use.
absSec_5">Conclusion
Fear of toxicity of magnesium sulfate was the main barrier towards timely and proper drug use. Periodic skill development and training of obstetricians, along with integration of the medical team in the work environment may contribute to decrease fear, broadening safety of drug prescription and thus reduce adverse outcomes related to PE and improving quality of maternal healthcare.
<a name="f0005">a>
ass="figTblUpiOute
r svA
rticle" id="figu
re_f0005">
ass="figure svArticle" id="f0005" data-t="f">- ass="autoScroll"><a class="figureLink" href="#fx29" title="Image for unlabelled figure">
ass="imgLazyJSB figure thumb" border="0" alt="Image for unlabelled figure" src="/sd/grey_pxl.gif" data-thumbEID="1-s2.0-S2210778916302781-fx29.sml" data-fullEID="1-s2.0-S2210778916302781-fx29.jpg" height="164" width="202" data-thumbheight="164" data-thumbwidth="202" data-fullheight="361" data-fullwidth="444">ript hspace="2" height="164" border="0" align="middle" width="202" vspace="2" alt="Image for unlabelled figure" title="Full-size image (70 K)" data-thumbEID="1-s2.0-S2210778916302781-fx29.sml" data-fullEID="1-s2.0-S2210778916302781-fx29.jpg">
ace="2" height="164" border="0" align="middle" width="202" vspace="2" alt="Image for unlabelled figure" title="Full-size image (70 K)" src="http://origin-ars.els-cdn.com/content/image/1-s2.0-S2210778916302781-fx29.sml" data-thumbEID="1-s2.0-S2210778916302781-fx29.sml" data-fullEID="1-s2.0-S2210778916302781-fx29.jpg">ript>a> - abelCaptionf0005">
ass="caption">
- ass="menuButtonLinks">
ass="btnHolde
r"><
a cl
ass="menuTitle" h
ref="#">Figu
re options
a>
ass="down_Btn">